Pfizer Australia’s A$180 Million Acquisition of ResApp

DLA Piper has advised ResApp Health Limited on the deal. ResApp Health Limited (ResApp) announced its A$180 million cash acquisition by Pfizer Australia Holdings Pty Limited…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now